While our vaccine delivery method resulted in a reduction in C. jejuni colonization, a delivery strategy resulting in an enhanced IgA production (i.e., mucosal delivery) may further reduce the colonization of C. jejuni. For example, mucosal delivery of influenza vaccine results in enhanced production of mucosal antibodies compare to intramuscular injection [75]. This evidence concerns the gene CD79A and influenza.